| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $8.9M | +155.5% |
| SG&A Expense | $6.1M | +43.2% |
| Operating Income | -$16.2M | -107.7% |
| Interest Expense | $7K | -99.2% |
| Pre-tax Income | -$15.8M | -25.4% |
| Net Income | -$15.8M | -25.4% |
| EPS (Basic) | -$1.75 | +26.2% |
| EPS (Diluted) | -$1.75 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $0 | — |
| Current Assets | $11.8M | +10.6% |
| Total Assets | $12.0M | +6.1% |
| Current Liabilities | $3.3M | +52.3% |
| Total Liabilities | $3.5M | +63.8% |
| Stockholders' Equity | $8.5M | -7.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.7M | -182.7% |
| Financing Cash Flow | $12.0M | -14.2% |
| +26.2% |